☆ 4.6 Article

FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer

PEERJ (2023)

Related references

Note: Only part of the references are listed.

Article Cell Biology

Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancers

Shaoyang Zhang et al.

Summary: The study shows that the protein SH3BGRL is elevated in breast cancer patients and is associated with relapse and poor prognosis. The upregulation of SH3BGRL enhances chemoresistance by promoting macroautophagic/autophagic protection in breast cancer cells, suggesting that targeting SH3BGRL could be a potential therapeutic strategy.

AUTOPHAGY (2022)

Add to Collection

Review Oncology

Autophagy and ncRNAs: Dangerous Liaisons in the Crosstalk between the Tumor and Its Microenvironment

Gracie Wee Ling Eng et al.

Summary: Tumor cells communicate with stromal cells through the secretion of extracellular vesicles, promoting tumor growth and metastasis. Autophagy plays a crucial role in the crosstalk between tumor and microenvironment by regulating the secretion and uptake of non-coding RNA.

CANCERS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases

Fangqi Xia et al.

Summary: This review explores the biological functions, underlying mechanisms, and pathogenic roles of long non-coding RNA KCNQ1OT1 in human diseases. KCNQ1OT1, classified as a regulatory non-coding RNA, interacts with miRNAs, RNAs, and proteins, thereby affecting gene expression and various cell functions. Dysregulation of KCNQ1OT1 is observed in a wide range of human diseases, making it a potential therapeutic target.

GENES & DISEASES (2022)

Add to Collection

Article Nanoscience & Nanotechnology

Novel Platinum Nanoclusters Activate PI3K/AKT/mTOR Signaling Pathway-Mediated Autophagy for Cisplatin-Resistant Ovarian Cancer Therapy

Mengjun Zhang et al.

Summary: This study demonstrates the anti-tumor effects of polyethylenimine-caged platinum nanoclusters on cisplatin-resistant ovarian cancer cells, inhibiting proliferation and migration while promoting apoptosis. The study also validates the role of these nanoclusters in regulating autophagy through the PI3K-AKT-mTOR signaling pathway. These findings suggest the promising potential of platinum nanoclusters as a novel chemotherapeutic agent for cisplatin-resistant ovarian cancer.

ACS APPLIED MATERIALS & INTERFACES (2022)

Add to Collection

Article Oncology

Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma

Yang Liu et al.

Summary: F. nucleatum infection was found to reduce chemotherapeutic response in ESCC patients, by modulating autophagy to induce resistance against 5-FU, CDDP, and Docetaxel. Targeting F. nucleatum during chemotherapy may lead to improved therapeutic outcomes for ESCC patients.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Review Oncology

Clinical perspectives of BET inhibition in ovarian cancer

Angeliki Andrikopoulou et al.

Summary: BET proteins have emerged as new druggable targets for ovarian cancer. BET inhibitors may enhance antitumor activity when co-administered with conventional treatment regimens. Results from ongoing Phase I/II studies are anticipated to confirm this notion.

CELLULAR ONCOLOGY (2021)

Add to Collection

Article Cell Biology

Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway

Xiao-Zhong Liao et al.

Summary: The study demonstrates that the combination of cordycepin (Cor) and cisplatin (DDP) has a synergistic effect on inhibiting proliferation and promoting apoptosis of non-small cell lung cancer (NSCLC) cells. The synergistic actions are associated with the activation of AMPK and inhibition of the AKT pathway. This combination therapy may offer a new therapeutic option for DDP-resistant NSCLC.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Oncology

Caveolin-1 promotes radioresistance via IRGM-regulated autophagy in lung cancer

Xi Chen et al.

Summary: The study demonstrates that Cav1 is involved in the development of IR resistance in NSCLC through IRGM-regulated autophagy, and can be considered as a potential therapeutic target for improving the radiosensitivity of NSCLC.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma

Hiroaki Kanzaki et al.

Summary: Inhibiting FGFR4/ERK signaling can enhance the efficacy of MKI treatment in HCC. Serum FGF19 levels may serve as a predictive marker for drug response and survival in HCC patients treated with sorafenib.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Multidisciplinary Sciences

LINC00963/miR-4458 regulates the effect of oxaliplatin in gastric cancer by mediating autophagic flux through targeting of ATG16L1

Meng Hou et al.

Summary: The study suggests that LINC00963 and miR-4458 may serve as potential biomarkers for predicting the overall survival of gastric cancer patients. Inhibiting LINC00963 to reduce autophagic flux can increase the sensitivity of gastric cancer cells to oxaliplatin, providing a potential novel therapeutic target for improving oxaliplatin sensitivity.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Obstetrics & Gynecology

Ultrasound characteristics of early-stage high-grade serous ovarian cancer

Elizabeth Suh-Burgmann et al.

Summary: This study aimed to evaluate the ultrasound findings associated with clinically detected early-stage high-grade serous ovarian cancer. Early-stage high-grade serous cancers rarely presented as masses of <5 cm or masses without solid components other than septations.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Genetics & Heredity

Prognostic Autophagy-Related Genes of Gastric Cancer Patients on Chemotherapy

Xiaolong Liu et al.

Summary: This study investigated the chemotherapy susceptibility of gastric cancer patients by combining autophagy-related genes. Nine genes related to chemotherapy prognosis were identified, and a model accurately predicted the outcomes of chemotherapy. This research provides better individualized treatment regimens for clinical practice.

FRONTIERS IN GENETICS (2021)

Add to Collection

Review Oncology

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer

Bayley G. Matthews et al.

Summary: High-grade serous ovarian cancer (HGSOC) is the most common subtype of ovarian cancer, with a stagnant overall survival rate over the past three decades. Chemoresistance remains a major challenge in treating HGSOC, and may be driven by epigenetic modifications. Identifying epigenetic changes in chemoresistant HGSOC allows for the development of targeted therapies to improve outcomes.

CANCERS (2021)

Add to Collection

Article Cell Biology

Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin via Suppressing PI3K/AKT and MAPK Signaling Pathways

Hefei Li et al.

Summary: Lung cancer is the leading cause of cancer death globally. Cisplatin is a common DNA-damaging drug used in treatment, but resistance often develops. Halofuginone has been identified as a sensitizing agent in lung cancer, inhibiting cell proliferation and inducing apoptosis by affecting PI3K/AKT and MAPK signaling pathways.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Respiratory System

Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer

Jia Chen et al.

Summary: The study found that FGF19 is significantly upregulated in NSCLC, and high FGF19 expression is correlated with reduced overall survival, especially in cases of lung adenocarcinoma (LUAD). FGF19 may serve as a potential biomarker for predicting poor overall survival in NSCLC patients.

JOURNAL OF THORACIC DISEASE (2021)

Add to Collection

Article Neurosciences

FGF-2 suppresses neuronal autophagy by regulating the PI3K/Akt pathway in subarachnoid hemorrhage

Yue Wang et al.

Summary: This study demonstrates that FGF-2 may exert neuroprotective effects in a SAH rat model by suppressing autophagy levels and activating the PI3K/Akt pathway, highlighting FGF-2 as a promising solution for clinical intervention in SAH.

BRAIN RESEARCH BULLETIN (2021)

Add to Collection

Review Oncology

Synthetic Lethality in Ovarian Cancer

Akshaya Chandrasekaran et al.

Summary: This article summarizes key information on overcoming chemoresistance in ovarian cancer using synthetic lethality strategies, including the biological rationale and clinical evaluation of targeting BRCA-PARP synthetic lethality. In addition, it also discusses how to apply synthetic lethality strategies in non-BRCA mutant cancers, along with the combination of PARP inhibitors and other methods to target ovarian cancer.

MOLECULAR CANCER THERAPEUTICS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy

You-Han Miao et al.

Summary: The study found that ZnO-NP can inhibit the proliferation, migration, and invasion of GC cells, induce apoptosis, and alleviate chemotherapy resistance. ZnO-NP regulates chemotherapy resistance in GC cells by inhibiting autophagy, making it a potential candidate for GC treatment.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Cell Biology

PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway

Zhiqiang Han et al.

Summary: PNO1 is overexpressed in hepatocellular carcinoma (HCC) and promotes autophagy while inhibiting apoptosis of HCC cells through the MAPK signaling pathway, thereby advancing the progression of HCC.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Multidisciplinary Sciences

IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation

Fuqing Hu et al.

Summary: IL-6 activates autophagy in colorectal cancer through the interaction between JAK2 and autophagy regulator BECN1, leading to chemotherapeutic resistance. BECN1 Y333 phosphorylation is crucial for BECN1 activation and IL-6-induced autophagy by regulating PI3KC3 complex formation. Combination treatment targeting the IL-6/JAK2/BECN1 signaling pathway may be a potential strategy for CRC therapy.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Oncology

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux

Yujie Zhao et al.

Summary: Innate and acquired platinum resistance are major challenges in the treatment of epithelial ovarian cancer (EOC). Exo70, a key subunit of the exocyst, plays a role in both types of resistance, and targeting Exo70 could be a promising approach to overcome cisplatin resistance in EOC treatment.

CANCERS (2021)

Add to Collection

Review Cell Biology

Developments in the study of gastrointestinal microbiome disorders affected by FGF19 in the occurrence and development of colorectal neoplasms

Meichang Peng et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways

Tian Wei et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection

Article Cell Biology

Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo

Jiangjiang Fan et al.

CELL DEATH & DISEASE (2020)

Add to Collection

Article Medicine, Research & Experimental

Fibroblast growth factor-21 alleviates hypoxia/reoxygenation injury in H9c2 cardiomyocytes by promoting autophagic flux

Zhong Ren et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)

Add to Collection

Article Medicine, Research & Experimental

Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4-and HIF-1α-mediated regulation of apoptosis and autophagy

Xiaofei Zhang et al.

THERANOSTICS (2019)

Add to Collection

Article Cell Biology

Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer

Ying Chen et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)

Add to Collection

Article Oncology

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells

Hong Yuan et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)

Add to Collection

Review Pharmacology & Pharmacy

Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach

Marco Presta et al.

PHARMACOLOGY & THERAPEUTICS (2017)

Add to Collection

Article Oncology

FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3β-Nrf2 Signaling

Yong Teng et al.

CANCER RESEARCH (2017)

Add to Collection

Article Oncology

Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer

Lingling Hu et al.

ONCOLOGY REPORTS (2015)

Add to Collection

Article Immunology

Autophagy activation by interferon-γ via the p38 mitogen-activated protein kinase signalling pathway is involved in macrophage bactericidal activity

Takeshi Matsuzawa et al.

IMMUNOLOGY (2014)

Add to Collection

Article Oncology

Autophagy contributes to resistance of tumor cells to ionizing radiation

Hassan Chaachouay et al.

RADIOTHERAPY AND ONCOLOGY (2011)

Add to Collection

Article Biochemistry & Molecular Biology

Coordinated regulation of autophagy by p38α MAPK through mAtg9 and p38IP

Jemma L. Webber et al.

EMBO JOURNAL (2010)

Add to Collection

Review Biochemistry & Molecular Biology

Autophagy in the pathogenesis of disease

Beth Levine et al.

CELL (2008)

Add to Collection

Review Genetics & Heredity

Evolution of the Fgf and Fgfr gene families

N Itoh et al.

TRENDS IN GENETICS (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.